author-photo

Ute Müh

Vertex Pharmaceuticals

25

Papers

1638

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions

2017 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (31)
Observed in Clinical Studies of Telaprevir Hepatitis C Virus NS3 Protease Variants Phenotypic Characterization of In Vitro

2013
Show All
- Source
- Cite
- Save
Citations (0)
Composés pyrimidine en tant quinhibiteurs de la tuberculose

2010
Show All
- Source
- Cite
- Save
Citations (0)
Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

2008 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (94)
[12] TELAPREVIR (VX-950) IS A POTENT INHIBITOR OF HCV NS3 PROTEASES DERIVED FROM GENOTYPE NON-1 HCV-INFECTED PATIENTS

2007 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (8)
Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

2007 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (569)
Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha.

2007 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (83)
Phenotypic and structural analyses of HCV NS3 protease ARG155 variants: Sensitivity to telaprevir (VX-950) and interferon alpha

2007 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (70)
Novel Pseudomonas aeruginosa Quorum-Sensing Inhibitors Identified in an Ultra-High-Throughput Screen

2006 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (206)
12 Wild-type HCV NS3 protease re-emerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCV

2006 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (12)